Misoprostol Before Hysteroscopy in Infertile Cases

Kasr El Aini Hospital120 enrolled

Overview

The role of hysteroscopy in infertility investigation is to detect possible intrauterine changes that could interfere with implantation or growth or both of the conceptus, with the invention of miniature hysteroscope, it is possible to perform hysteroscopy in an office setting (Outpatient hysteroscopy; OH), for diagnostic and certain therapeutic intervention. It is currently acknowledged as the 'gold standard' investigation of the intrauterine abnormalities. Cervical priming prior to diagnostic hysteroscopy softens the cervix and lessens the force needed for dilation, thereby potentially reducing the probability of procedural complication such as uterine perforation, cervical laceration, failure to dilate, and creation of a false track that can occur during cervical entry. Misoprostol is a prostaglandin El analogue, that can be administered either orally or vaginally, that can cause cervical ripening by inducing collagenolytic activity and synthesis of proteoglycans.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

120

Conditions

Infertility

Interventions

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 40 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female patients aged from 20 to 40 years old. * They are complaining with primary or secondary infertility. * They undergo investigations including husband semen analysis, hormonal assay, U/S, Hystrosalpingography. Exclusion Criteria: * Known sensitivity to misoprostol. * Any systemic disease contraindicating the use of prostaglandins (cardiovascular disease, hypertension, renal failure, etc). * Concomitant neurologic disease that could affect the correct evaluation of pain. * Pregnancy. * Any contraindication to hysteroscopy such as Pelvic inflammatory disease (PID). * Heavy uterine bleeding. * Any uterine abnormality such as pinhole cervix that would obviate passage of a catheter through the cervix.

Outcomes

Primary Outcomes

level of pelvic pain according to a 10-point visual analogue scale (VAS)

The level of pelvic pain will be rated according to a 10-point visual analogue scale (VAS). The VAS will be applied immediately after the procedure ended

Time frame: 10 months